New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
Open Access
- 1 April 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (2), 112-120
- https://doi.org/10.1215/15228517-2007-052
Abstract
The blood-brain barrier is a substantial obstacle for delivering anticancer agents to brain tumors, and new strategies for bypassing it are greatly needed for brain-tumor therapy. Intranasal delivery provides a practical, noninvasive method for delivering therapeutic agents to the brain and could provide an alternative to intravenous injection and convection-enhanced delivery. We treated rats bearing intracerebral human tumor xenografts intranasally with GRN163, an oligonucleotide N3'→P5'thio-phosphoramidate telomerase inhibitor. 3'-Fuorescein isothiocyanate (FITC) - labeled GRN163 was administered intranasally every 2 min as 6 μl drops into alternating sides of the nasal cavity over 22 min. FITC-labeled GRN163 was present in tumor cells at all time points studied, and accumulation of GRN163 peaked at 4 h after delivery. Moreover, GRN163 delivered intranasally, daily for 12 days, significantly prolonged the median survival from 35 days in the control group to 75.5 days in the GRN163-treated group. Thus, intranasal delivery of GRN163 readily bypassed the blood-brain barrier, exhibited favorable tumor uptake, and inhibited tumor growth, leading to a prolonged lifespan for treated rats compared to controls. This delivery approach appears to kill tumor cells selectively, and no toxic effects were noted in normal brain tissue. These data support further development of intranasal delivery of tumor-specific therapeutic agents for brain tumor patients.Keywords
This publication has 28 references indexed in Scilit:
- Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcoholSurgical Neurology, 2006
- Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine modelJournal of Neurosurgery, 2004
- Intranasal insulin improves memory in humansPsychoneuroendocrinology, 2004
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002
- Delivery of Neurotrophic Factors to the Central Nervous SystemClinical Pharmacokinetics, 2001
- The blood-brain and blood-tumor barriers: A review of strategies for increasing drug deliveryNeuro-Oncology, 2000
- The blood-brain and blood-tumor barriers: A review of strategies for increasing drug deliveryNeuro-Oncology, 2000
- Transnasal Delivery of 5-Fluorouracil to the Brain in the RatJournal of Drug Targeting, 1999
- Quantitative analysis of the olfactory pathway for drug delivery to the brainBrain Research, 1995
- Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkeyJournal of Comparative Neurology, 1986